NLRP1 and colorectal carcinoma: Despite NLRP1 expression had no significant correlation with the TMB or MSI (p = 0.219 and p = 0.074, respectively), our results indicated that low NLRP1 expression also might benefit from immunotherapy in CRC (p < 0.001).